print small large

This application is a service of the Singapore Government.

Health Sciences Authority

Archive

PAST NOTIFICATIONS

18 Oct 2012 Telfast D has been reclassified from POM to P. This is a product-specific reclassification
4 July 2012 Telfast 120mg has been reclassified from POM to P. This is a product-specific reclassification
1 July 2012

The following list includes medicines which have been reclassified or are POM granted exemptions for supply without a prescription. Please use the Online Infosearch instead to determine the updated forensic classification of specific products if these cannot be found from this site.  

New POMs granted exemptions for limited sale and supply without prescription

Active Ingredient Exemptions for supply of POM without prescription (Active ingredient remains as POM if these criteria are not met)
Azelaic Acid

As a topical preparation containing 20% w/w 

  • Indications: Mild to moderate Acne Vulgaris
  • Maximum daily dose: Apply to the affected area twice daily
  • Maximum supply: 30g
  • Minimum age: 12 years
Triamcinolone Acetonide

As an intranasal spray containing not more than 55 mcg / actuation 

  • Indication: Prevention and treatment of allergic rhinitis
  • Maximum daily dose: 220 mcg
  • Maximum supply: 3 months
  • Minimum age: 18 years
Levocetirizine

As an oral solid preparation containing not more than 5 mg 

  • Indication: For the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria
  • Maximum daily dose: 5mg
  • Maximum supply: 10 tablets
  • Minimum age: 12 years

As an oral liquid preparation containing not more than 5mg / ml

  • Indication: As above
  • Maximum daily dose: As above
  • Maximum supply: 1 bottle
  • Minimum age: As above

Amendments to current exemptions for supply without prescription

Active Ingredient Exemptions for supply of POM without prescription (Active ingredient remains as POM if these criteria are not met)
Ibuprofen

As an oral solid preparation containing not more than 200mg 

  • Indications: Relief of headache, menstrual pain, backache, muscular and arthritic pain, toothache, and the aches of cold and flu and reduction of fever.
  • Maximum daily dose: 1.2g
  • Maximum Supply: 10 days. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms
  • Minimum age: 12 years

As an oral liquid preparation not more than 100mg / 5ml

  • Indications: Reduction of fever, including post-immunisation pyrexia, and relief of mild to moderate pain such as sore throat, teething pain and toothache, earache, minor aches and sprains
  • Maximum Daily Dose: 30 mg / kg, up to a maximum of 1.2g
  • Maximum Supply: 3 days. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms
  • Minimum age: 6 months
Domperidone

As an oral solid prepartion containing not more than 10mg, or an oral liquid preparation containing not more than 1mg / ml

  • Indications: Relief of postprandial symptoms of excessive fullness, nausea, epigastric bloating and belching occasionally accompanied by epigastric discomfort and heartburn
  • Maximum Daily Dose: 30 mg
  • Maximum supply: 14 days
  • Minimum age: 12 years
19 March 2012 Aerius 5mg tablet has been reclassified from POM to P.
17 February 2012 Flixonase Aqueous Nasal Spray 0.05% has been reclassified from POM to P. This is a product-specific reclassification.
1 February 2012 A list of products has been reclassified from P to POM effective from February 2012 and earlier.  Click here to view the list of medicinal products tdat are reclassified from P to POM.
12 January 2012 Clarityne (loratadine) tablets 10's has been reclassified from P to GSL under the new brand name of 'Clarityn'. this will be available with a new PIL, outer carton and in packs of 10's only. this is a product-specific reclassification

1 January 2012

The following list includes medicines which have been reclassified or are POM granted exemptions for supply without a prescription. Please use the Online Infosearch instead to determine the updated forensic classification of specific products if these cannot be found from this site.

New POMs with exemptions for supply without prescription

Active Ingredient

Exemptions for supply of POM without prescription (Active ingredient remains as POM if these criteria are not met)

Desloratadine / Pseudoephedrine

As a modified release oral solid dosage form containing desloratadine 2.5mg and pseudoephedrine 120mg

  • Indications: For the relief of symptoms associated with allergic rhinitis including nasal congestion, sneezing, runny nose, itching of the nose and/or eyes.

    It should be administered when both the antihistaminic properties of desloratadine and the decongestant effect of pseudoephedrine are required.

    Dosing regimen: 1 tablet twice daily

  • Maximum daily dose: 2 tablets
  • Maximum supply: 10 tablets
  • Minimum age: 12 years

Fexofenadine / Pseudoephedrine*

As a modified release oral solid dosage form containing fexofenadine 60mg and pseudoephedrine 120mg

  • Indications: For the relief of symptoms associated with allergic rhinitis including nasal congestion, sneezing , runny nose, itching of the nose and/or eyes.

    It should be administered when both the antihistaminic properties of fexofenadine and the decongestant effect of pseudoephedrine are required.

    Dosing regimen: 1 tablet twice daily

  • Maximum daily dose: 2 tablets
  • Maximum supply: 10 tablets
  • Minimum age: 12 years

* This exemption has been removed with effect from 1 Jan 2013

Ketotifen

As eyedrops not exceeding 0.25mg/ml

  • Indications:For the short-term treatment of symptoms of allergic conjunctivitis (e.g. itchy or watery eyes)

    Dosing regimen: Adults, elderly and children (age 3 and older): One drop into the affected eye (s) twice daily (in the morning and evening)

  • Maximum daily dose: 2 drops per affected eye
  • Maximum supply: 10ml
  • Minimum age: 3 years

Amendments to current exemptions for supply without prescription

Active Ingredient

Exemptions for supply of POM without prescription (Active ingredient remains as POM if these criteria are not met)

Ibuprofen 

As an oral solid preparation containing not more than 200mg

  • Indications:Relief of headache, menstrual pain, backache, muscular and arthritic pain, toothache, and the aches of cold and flu and reduction of fever.
  • Maximum daily dose: 1.2g
  • Maximum Supply: 10 days. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms.
  • Minimum age: 12 years

As an oral liquid preparation not more than 100mg / 5ml *

  • Indications: Reduction of fever, including post-immunisation pyrexia, and relief of mild to moderate pain such as sore throat, teething pain and toothache, earache, minor aches and sprains
  • Maximum Daily Dose:
    6 -12 months: 150-200mg
    1-4 years: 250mg
    4-7 years: 450mg
    7-10 years: 600mg
    10-12 years: 900mg
  • Maximum Supply: 3 days. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms.
  • Minimum age: 6 months

* The exemptions have been amended with effect from 1 July 2012.

Click here for recent updates